Based on his leading experience with the hydrophilic polymer coating (HPC)-coated pEGASUS stent (phenox) at his centre, and positive, early observations of this easy-to-use device, André Kemmling (University Medical Center Marburg, Marburg, Germany) details the benefits of surface modification in treating a greater number of intracranial aneurysm patients while reducing the need for dual antiplatelet therapy.
The pEGASUS stent is indicated for patients with intracranial aneurysms as well as stenoses in intracranial atherosclerotic disease (ICAD) patients.
This video is sponsored by phenox.
